Meningitis Diagnostic Testing Market: Outlook

Rapid innovations and upgradations in the healthcare and diagnostic technologies that allows for precise diagnostics in minimal time are positively influencing the demand within the global meningitis diagnostic testing market. Furthermore, the increase in the research and development activities intended for developing novel and accurate meningitis diagnosis solutions is also expected to bolster the demand dynamics within the global meningitis diagnostic testing market over the forecast period of 2017 to 2025. However, lack of skilled technicians that can operate or handle advanced technological solutions and testing equipment may hamper the growth in the global meningitis diagnostic testing market in coming years.

According to the corporate research report by the Transparency Market Research, the global meningitis diagnostic testing market is expected to expand at a steady growth rate of 3 % over the forecast period of 2017 to 2025. The research report also predicts that the global meningitis diagnostic testing market will surpass the evaluation of US$ 150.0 million by the end of the forecast period i.e. 2025. It also informs the readers that the global meningitis diagnostic testing market was evaluated at US$ 105 million in the beginning of the forecast period i.e. 2016.rising adoption of the solutions in the global meningitis diagnostic testing market as well as easy availability of lateral flow assay are aiding in the expansion of the industry.

meningitis-diagnostic-testing-market.jpg

Rising Prevalence of Meningitis Fuels Demand in Meningitis Diagnostic Testing Market

The increasing demand for point of care services is likely to drive growth within the global meningitis diagnostic testing market in coming years. The point of care services offer more precise results in less time as compared to the conventional meningitis diagnostic testing methods. Furthermore, rising prevalence of meningitis is anticipated to drive the growth within the global meningitis diagnostic testing market in near future. On the other hand, presence of complex and stringent regulatory framework may hamper the development of the global meningitis diagnostic testing market in coming years.

The types of products offered by the players and manufacturers in the global meningitis diagnostic testing market include lateral flow assay, ELISA tests, latex agglutination tests, PCR tests, and culture tests, among others. The PCR test segment amounted for the highest industry share in terms of revenue in the global meningitis diagnostic testing market in 2016. The PCR testing solutions offer a higher sensitivity rate of almost 97 % and provide results faster than the traditional testing methods. Moreover, another segment anticipated to expand at a stellar rate in coming years within the global meningitis diagnostic testing market is lateral flow assay. This trend can be attributed to the low cost, reliable, and rapid nature of the lateral flow assay tests.

End users for the products and solutions offered by the players and manufacturers in the global meningitis diagnostic testing market are diagnostic centers and hospitals, among others. Among these, the hospital segment accounted for the largest share within the global meningitis diagnostic testing market in the year 2016. This trend can be attributed to the rising number of international hospitals that feature technologically superior laboratory infrastructure.

Asia Pacific to Record Highest Growth Rate in Meningitis Diagnostic Testing Market in Near Future

Major regions and leading nations in the global meningitis diagnostic testing market include Europe (including Germany, Italy, the United Kingdom, France, Spain, and rest of the Europe), Latin America (including Mexico, Brazil, and rest of the Latin America), North America (including the United States and Canada), Middle East and Africa (including Sub Saharan Africa, Middle East and North Africa, and rest of the Middle East and Africa), and Asia Pacific (including Japan, Australia, India, New Zealand, China, and rest of the Asia Pacific). Among these, the North America region dominated the global meningitis diagnostic testing market in 2016. The regional market with second largest share in the global meningitis diagnostic testing market in 2016 was Asia Pacific.

Rising patient awareness as well as the easy availability of rapid diagnostic testing equipment and kits are some of the major contributors for the expansion of the global meningitis diagnostic testing market in North America region. On the other hand, Asia Pacific global meningitis diagnostic testing market is set to expand at the highest growth rate over the forecast period owing to massive population base in some of the major nations in the region, such as India and China. Furthermore, increase in the patient awareness as well as developing laboratory infrastructure in the region is also expected to bolster the growth of Asia Pacific region in the global meningitis diagnostic testing market in near future.

Players in Meningitis Diagnostic Testing Market Engaged in Acquisitions and Collaborations

Few of the most notable players and manufacturers operational within the global meningitis diagnostic testing market are Fast Track Diagnostics Ltd. (FTD), Bio-Rad Laboratories, Inc., BioFire Diagnostics, Luminex Corporation, Qnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers, IMMY, Nanosphere, Seegene Inc., and ELI Tech Group, among others. Major players and manufacturers in the global meningitis diagnostic testing market are focused on expanding their geographical presence as well as on diversifying their product portfolios by providing their conusmers with technologically advanced meningitis diagnostic testing solutions.

The research report also predicts that the global meningitis diagnostic testing market will expand at a stellar pace owing to the increasing demand for technologically superior meningitis diagnostic testing kits. This trend is anticipated to further intensify the competition within the global meningitis diagnostic testing market. Players and manufacturers in the global meningitis diagnostic testing market are engaged in corporate growth strategies such as strategic collaborations as well as acquisitions in order to capture a larger consumer base.

Meningitis Diagnostic Testing Market: Overview

This report on meningitis diagnostic testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing diagnostic test for meningitis as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global meningitis diagnostic testing market with respect to the leading market segments based on product type, end-user and geographies.

Meningitis Diagnostic Testing Market: Segmentations

The global meningitis diagnostic testing market is divided into three segments: by product, by end user and by geography. Based on the product, the market has been further segmented into six major sub segments latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. The market has been further studied from the point of view of end user. Based on end user, the market has been segmented into hospitals, diagnostics centers and others

Each of the market segments have been extensively analyzed based on the market related factors such as increase incidence of meningitis and available testing options. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the meningitis diagnostic testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global meningitis diagnostic testing market.

Geographically, meningitis diagnostic testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global meningitis diagnostic testing market.

Meningitis Diagnostic Testing Market: Competitive Landscape

Major players operating in the global meningitis diagnostic testing market are Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup,  and Abbott Laboratories exhibit the largest geographical outreach with presence in multiple meningitis diagnostic testing products

The global meningitis diagnostic testing market is segmented as follows:

Product

  • Latex Agglutination Tests
  • Lateral Flow Assay
  • PCR Assay
  • ELISA Tests
  • Culture Test
  • Others

End User

  • Hospital
  • Diagnostic Centers
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • Middle East & North Africa
    • Sub-Saharan Africa
    • Rest of Middle East & Africa

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Meningitis Diagnostic Testing Market Snapshot

4. Market Overview
     4.1. Product Overview
     4.2. Key Industry Events 
     4.3. Global Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, 2015-2025 
     4.4. Market Opportunity Map
     4.5. Porter’s Analysis 
     4.6. Global Meningitis Diagnostic Testing Market Outlook

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Trends
     5.1. Key Success factor for Top Players
     5.2. Key Mergers and Acquisitions-In vitro Diagnostics (IVD) Industry 
     5.3. Regulatory Scenario

6. Global Meningitis Diagnostic Testing Market Analysis, by Product
     6.1. Introduction
     6.2. Key Findings
     6.3. Global Meningitis Diagnostic Testing Market Value Share, by Product 
     6.4. Global Meningitis Diagnostic Testing Market Forecast, by Product
            6.4.1. Latex Agglutination Tests 
            6.4.2. Lateral Flow Assay
            6.4.3. PCR Assay
            6.4.4. ELISA Tests 
            6.4.5. Culture Test
            6.4.6. Others
     6.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product

7. Global Meningitis Diagnostics Testing Market Analysis, by End User
     7.1. Introduction
     7.2. Key Findings
     7.3. Global Meningitis Diagnostic Testing Market Value Share Analysis, by End User
     7.4. Global Meningitis Diagnostic Testing Market Forecast, by End User
            7.4.1. Hospital
            7.4.2. Diagnostic Center
            7.4.3. Others
     7.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by End User

8. Global Meningitis Diagnostic Testing Market Analysis, by Region
     8.1. Global Market Scenario by Country
     8.2. Global Meningitis Diagnostic Testing Market Value Share Analysis, by Region
     8.3. Global Meningitis Diagnostic Testing Forecast, by Region
            8.3.1. North America
            8.3.2. Europe
            8.3.3. Asia Pacific
            8.3.4. Latin America
            8.3.5. Middle East & Africa
     8.4. Global Meningitis Diagnostic Testing Attractiveness Analysis By Region

9. North America Meningitis Diagnostic Testing Market Analysis
     9.1. Key Findings
     9.2. Market Overview
     9.3. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
     9.4. North America Meningitis Diagnostic Testing Market Forecast, by Country
     9.5. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
     9.6. North America Meningitis Diagnostic Testing Market Forecast, by Product
            9.6.1. Latex Agglutination Tests 
            9.6.2. Lateral Flow Assay
            9.6.3. PCR Assay
            9.6.4. ELISA Tests 
            9.6.5. Culture Test
            9.6.6. Others
     9.7. North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
     9.8. North America Meningitis Diagnostic Testing Market Forecast, by End-user
            9.8.1. Hospital
            9.8.2. Diagnostic Center
            9.8.3. Others
     9.9. North America Meningitis Diagnostic Testing Market Attractiveness Analysis

10. Europe Meningitis Diagnostic Testing Market Analysis
     10.1. Key Findings
     10.2. Market Overview
     10.3. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country
     10.4. Europe Meningitis Diagnostic Testing Market Forecast, by Country
            10.4.1. U.S.
            10.4.2. Canada
     10.5. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product
     10.6. Europe Meningitis Diagnostic Testing Market Forecast, by Product
            10.6.1. Latex Agglutination Tests 
            10.6.2. Lateral Flow Assay
            10.6.3. PCR Assay
            10.6.4. ELISA Tests 
            10.6.5. Culture Test
            10.6.6. Others
     10.7. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
     10.8. Europe Meningitis Diagnostic Testing Market Forecast, by End-user
            10.8.1. Hospital
            10.8.2. Diagnostic Center
            10.8.3. Others
     10.9. Europe Meningitis Diagnostic Testing Market Attractiveness Analysis

11. Asia Pacific Meningitis Diagnostic Testing Market Analysis
     11.1. Key Findings
     11.2. Market Overview
     11.3. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country
     11.4. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Country
            11.4.1. U.K.
            11.4.2. Germany
            11.4.3. France
            11.4.4. Italy
            11.4.5. Spain
            11.4.6. Rest of Europe
     11.5. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product
     11.6. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Product
            11.6.1. Latex Agglutination Tests 
            11.6.2. Lateral Flow Assay
            11.6.3. PCR Assay
            11.6.4. ELISA Tests 
            11.6.5. Culture Test
            11.6.6. Others
     11.7. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
     11.8. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by End-user
            11.8.1. Hospital
            11.8.2. Diagnostic Center
            11.8.3. Others
     11.9. Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis

12. Latin America Meningitis Diagnostic Testing Market Analysis
     12.1. Key Findings
     12.2. Market Overview
     12.3. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
            12.3.1. Brazil
            12.3.2. Mexico
            12.3.3. Rest of Latin America
     12.4. Latin America Meningitis Diagnostic Testing Market Forecast, by Country
     12.5. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
     12.6. Latin America Meningitis Diagnostic Testing Market Forecast, by Product
            12.6.1. Latex Agglutination Tests 
            12.6.2. Lateral Flow Assay
            12.6.3. PCR Assay
            12.6.4. ELISA Tests 
            12.6.5. Culture Test
            12.6.6. Others
     12.7. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
     12.8. Latin America Meningitis Diagnostic Testing Market Forecast, by End-user
            12.8.1. Hospital
            12.8.2. Diagnostic Center
            12.8.3. Others
     12.9. Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis

13. Middle East & Africa Meningitis Diagnostic Testing Market Analysis
     13.1. Key Findings
     13.2. Market Overview
     13.3. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country
            13.3.1. Middle East & North Africa
            13.3.2. Sub-Saharan Africa
            13.3.3. Rest of Africa
     13.4. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Country
     13.5. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product
     13.6. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Product
            13.6.1. Latex Agglutination Tests 
            13.6.2. Lateral Flow Assay
            13.6.3. PCR Assay
            13.6.4. ELISA Tests 
            13.6.5. Culture Test
            13.6.6. Others
     13.7. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
     13.8. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by End-user
            13.8.1. Hospital
            13.8.2. Diagnostic Center
            13.8.3. Others
     13.9. Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis

14. Competition Landscape
     14.1. Meningitis Diagnostic Testing Market Share Analysis By Company, 2015
     14.2. Competition Matrix
     14.3. Company Profiles
            14.3.1. Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers 
                      14.3.1.1. Company Details
                      14.3.1.2. Business Overview
                      14.3.1.3. Financial Overview
                      14.3.1.4. Strategic Overview
                      14.3.1.5. SWOT Analysis
            14.3.2. Thermo Fisher Scientific, Inc.
                      14.3.2.1. Company Details
                      14.3.2.2. Business Overview
                      14.3.2.3. Financial Overview
                      14.3.2.4. Strategic Overview
                      14.3.2.5. SWOT Analysis
            14.3.3. Abbott Laboratories.
                      14.3.3.1. Company Details
                      14.3.3.2. Business Overview
                      14.3.3.3. Financial Overview
                      14.3.3.4. Strategic Overview
                      14.3.3.5. SWOT Analysis
            14.3.4. Bio-Rad Laboratories, Inc.
                      14.3.4.1. Company Details
                      14.3.4.2. Business Overview
                      14.3.4.3. Financial Overview
                      14.3.4.4. Strategic Overview
                      14.3.4.5. SWOT Analysis
            14.3.5. Seegene Inc.
                      14.3.5.1. Company Details
                      14.3.5.2. Business Overview
                      14.3.5.3. Financial Overview
                      14.3.5.4. Strategic Overview
                      14.3.5.5. SWOT Analysis
            14.3.6. DiagCor Bioscience Inc. Ltd
                      14.3.6.1. Company Details
                      14.3.6.2. Business Overview
                      14.3.6.3. Financial Overview
                      14.3.6.4. Strategic Overview
                      14.3.6.5. SWOT Analysis
            14.3.7. BioFire Diagnostics (bioMerieux)
                      14.3.7.1. Company Details
                      14.3.7.2. Business Overview
                      14.3.7.3. Financial Overview
                      14.3.7.4. Strategic Overview
                      14.3.7.5. SWOT Analysis
            14.3.8. IMMY
                      14.3.8.1. Company Details
                      14.3.8.2. Business Overview
                      14.3.8.3. Financial Overview
                      14.3.8.4. Strategic Overview
                      14.3.8.5. SWOT Analysis
            14.3.9. Nanosphere (Luminex Corporation).
                      14.3.9.1. Company Details
                      14.3.9.2. Business Overview
                      14.3.9.3. Financial Overview
                      14.3.9.4. Strategic Overview
                      14.3.9.5. SWOT Analysis

List of Tables

TABLE 1 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by Product, 2015–2025
TABLE 2 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 3 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
TABLE 4 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 5 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 6 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 7 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country /Sub-region, 2015–2025
TABLE 8 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 9 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 10 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 11 Table 11: Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 12 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 13 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 14 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 15 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 16 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 17 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 18 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 19 Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers Business Overview
TABLE 20 Thermo Fisher Scientific, Inc. Business Overview
TABLE 21 Abbott Laboratories Business Overview
TABLE 22 Bio-Rad Laboratories, Inc. Business Overview
TABLE 23 Seegene Inc. Business Overview
TABLE 24 DiagCor Bioscience Inc. Ltd Business Overview
TABLE 25 BioFire Diagnostics (bioMérieux) Business Overview
TABLE 26 IMMY Business Overview
TABLE 27 Nanosphere (Luminex Corporation) Business Overview

List of Figures

FIG. 1 Global Meningitis Diagnostics Testing Market  Share (US$ Mn), by Product, 2016
FIG. 2 Global Meningitis Diagnostics Testing Market Share (%), by End User, 2016
FIG. 3 Revenue Share, by product, 2016
FIG. 4 Revenue Share, by end user, 2016
FIG. 5 Global Meningitis Diagnostic Testing Market  Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
FIG. 6 Market Value Share, by Product (2016)
FIG. 7 Market Value Share, by Distribution Channel (2016)
FIG. 8 Market Value Share, by Region (2016) 
FIG. 9 Global Meningitis Diagnostic Testing Market Value Share, by Product, 2016 and 2025
FIG. 10 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Latex Agglutination Test, 2015–2025
FIG. 11 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lateral Flow Assay, 2015–2025
FIG. 12 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCR Assay, 2015–2025
FIG. 13 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by ELISA Test, 2015–2025
FIG. 14 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Culture Test, 2015–2025
FIG. 15 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
FIG. 16 Global Meningitis Diagnostic Testing Market Attractiveness, by Product
FIG. 17 Global Meningitis Diagnostic Testing Market Value Share, by End-user, 2016 and 2025
FIG. 18 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
FIG. 19 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2015–2025
FIG. 20 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2015–2025
FIG. 21 Global Meningitis Diagnostic Testing Market Attractiveness, by End-user
FIG. 22 Global Meningitis Diagnostic Testing Market Value Share, by Region, 2016 and 2025
FIG. 23 Global Meningitis Diagnostic Testing Attractiveness Analysis, by Region, 2017–2025
FIG. 24 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 25 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country, 2017–2025
FIG. 26 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country, 2016 and 2025
FIG. 27 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 28 North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 29 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 30 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 31 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 32 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 33 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 34 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 35 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 36 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 37 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 38 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 39 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 40 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 41 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 42 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 43 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 44 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 45 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 46 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 47 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 48 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 49 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 50 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 51 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 52 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 53 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 54 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 55 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 56 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 57 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 58 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 59 Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
FIG. 60 Thermo Fisher Scientific, Inc. Research & Development Expenses (US$ Mn), 2015–2016
FIG. 61 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2016
FIG. 62 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2016
FIG. 63 Abbott Laboratories Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
FIG. 64 Abbott Laboratories Research & Development Expenses (US$ Bn), 2015–2016
FIG. 65 Abbott Laboratories Breakdown of Net Sales, by Region, 2016
FIG. 66 Abbott Laboratories Breakdown of Net Sales, by Segment, 2016
FIG. 67 Bio-Rad Laboratories, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 68 Bio-Rad Laboratories, Inc. Research & Development Expenses (US$ Mn), 2015–2016
FIG. 69 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Geography, 2016
FIG. 70 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Segment, 2016
FIG. 71 Seegene Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
FIG. 72 Seegene Inc. Research & Development Expenses (US$ Mn), 2014–2016
FIG. 73 Seegene Inc. Breakdown of Net Sales, by Region, 2016
FIG. 74 Seegene Inc. Breakdown of Net Sales, by Business Segment, 2016
FIG. 75 Nanosphere Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 76 Nanosphere  Research & Development Expenses (US$ Mn), 2014–2016
FIG. 77 Nanosphere Breakdown of Net Sales, by Business Segment, 2016

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Meningitis Diagnostic Testing Market